MedTrace Logo

Pharmacotyping of Pancreatic Patient-derived Organoids

NCT05196334 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2024-10-03

No results posted yet for this study

Summary

EUS-FNB samples will be used for organoid cultures, which will be co-cultured with cancer associated fibroblasts derived from the surrounding stroma of the lesion. The organoid cultures will be used for pharmacotyping using relevant chemotherapeutic agents used in the clinic, and the organoid's response compared with the patient's response.

Conditions

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    collaborator OTHER

  • Herlev Hospital

    lead OTHER

Principal Investigators

  • Pia H Klausen, PhD · Rigshospitalet, Denmark

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2025-08-30
Completion
2025-08-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05196334 on ClinicalTrials.gov